Position in NTRA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,510,369
+$1,605,693 QoQ
Shares Held
9,248
+134.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#340
of 844 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026AZZAD ASSET MANAGEMENT INC /ADV holds $22,374,173 across 11 Diagnostics & Research names. NTRA ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
4,164 | $5,319,551 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
9,403 | $4,950,115 | |
| 3 | DHR |
Danaher Corp /De/
|
25,961 | $4,945,051 | |
| 4 | NTRA |
Natera, Inc.
This page
|
9,248 | $2,510,369 | |
| 5 | ILMN |
Illumina, Inc.
|
9,823 | $1,727,178 | |
| 6 | WAT |
Waters Corp /De/
|
2,206 | $827,338 | |
| 7 | A |
Agilent Technologies, Inc.
|
5,106 | $678,229 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
915 | $484,574 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,510,369 | 9,248 | Shares | Sole | 2026-07-29 | |
| 2025-12-31 | $904,676 | 3,949 | Shares | Sole | 2026-01-21 | |
| No filing history on record for this holder in this stock. | ||||||